Employees: 978
Size Farglory Life Insurance (5859.TWO) is a Taiwan Financials company (Life/Health Insurance) with a market value of $614M, the 373rd largest of 648 Taiwan companies the cockpit tracks. Shares closed at NT$14.15 on 18 Nov 2026.
Performance Over six months the shares fell 1.1%, against -8.4% for the median peer and -3.4% for the Taiwan market (cap-weighted) — 5th highest of 11 in its peer set.
Growth Revenue fell 48.4% over the last twelve months (peer median +18.7%); the operating margin is -54.0% (peer median 6.7%).
Valuation It trades at 0.22× book value against a peer median of 1.08× (cheapest of 11).
Price implies The share price implies a return on equity of about 1.7%; Farglory Life Insurance delivers 7.1%, so the price asks less than the business earns today.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | NT$51.4B | NT$100B | NT$61.6B | NT$63.7B | NT$52.3B |
| Revenue growth | — | +63% | -3% | +22% | — |
| Net income | NT$5.62B | NT$4.63B | NT$7.22B | NT$2.21B | NT$6.07B |
| Free cash flow | NT$19.7B | NT$38.8B | NT$14.7B | NT$11.8B | NT$19.1B |
| Capital expenditure | NT$300M | NT$305M | NT$599M | NT$59.0M | NT$4.11B |
| Total debt | n/a | NT$330M | NT$237M | NT$320M | NT$266M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 5859.TWO | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.4% | -7.5% | 5th highest of 11 |
| 6-month return | -1.1% | -8.4% | 5th highest of 11 |
| Return on equity | 7.1% | 5.9% | 5th highest of 11 |
| Price / book | 0.22× | 1.08× | cheapest of 11 |
| Trailing P/E | 3.6× | 25.8× | cheapest of 10 |
| ROE the price implies | 1.7% | 6.5% | least demanding of 11 |
| ROE delivered | 7.1% | 5.9% | 5th highest of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| Farglory Life Insurance 5859.TWO | Taiwan | $614M | -1% | -48% | 7% | 0.22× | 1.7% | 7.1% |
| Lifenet Insurance 7157.T | Japan | $652M | -28% | +11% | 8% | 1.11× | 7.0% | 7.6% |
| Mercuries & Associates 2905.TW | Taiwan | $456M | +11% | -43% | -118% | 0.56× | 2.7% | -117.8% |
| Yunfeng Financial 0376.HK | Hong Kong | $872M | -24% | +21% | 7% | 0.53× | 7.4% | 6.7% |
| Canara HSBC Life Insurance CANHLIFE.NS | India | $1.29B | -8% | +17% | 8% | 7.36× | 50.5% | 8.2% |
| Niva Bupa Health Insurance NIVABUPA.NS | India | $1.46B | -9% | +58% | 14% | 3.55× | 32.5% | 13.9% |
| Nuernberger Beteiligungs NBG6.DE | Germany | $1.55B | +2% | -1% | 5% | 1.58× | 6.1% | 5.1% |
| Mirae Asset Life Insurance 085620.KS | South Korea | $1.70B | +19% | +152% | 2% | 1.06× | 5.8% | 1.8% |
| Hanwha Life 088350.KS | South Korea | $2.09B | -33% | +20% | 5% | 0.23× | 3.8% | 4.6% |
| Clover Health Investments CLOV | United States | $2.21B | +16% | +54% | 3% | 5.31× | 81.1% | 3.4% |
| Brighthouse Financial BHF | United States | $2.42B | -33% | -9% | 12% | 0.48× | 6.0% | 12.0% |